Aandelen in “Diensten aan de gezondheidssector”

Aandeel Datum Koers Evolutie
Geen effecten gevonden.

Nieuws over “Diensten aan de gezondheidssector”

9/05 · Cegedim: plan to transfer its shares to Euronext Growth Paris. · Persbericht

9/05 · Cegedim: plan to transfer its shares to Euronext Growth Paris. · Persbericht

8/05 · Labcorp to Webcast Its Annual Meeting of Shareholders May 15 · Persbericht

7/05 · Promethean partners with Google on powerful plug-in ChromeOS device · Persbericht

1/05 · Promethean's ActivPanel 10 Premium wins prestigious Red Dot Design Award 2025 · Persbericht

30/04 · Equasens: EXCLUSIVE NEGOTIATIONS INITIATED WITH A FRENCH SOFTWARE EDITOR · Persbericht

29/04 · Labcorp Announces 2025 First Quarter Results · Persbericht

24/04 · Cegedim: Like-for-like revenues grew 4.5% in the first quarter · Persbericht

23/04 · Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions · Persbericht

22/04 · Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025 · Persbericht

18/04 · DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS · Persbericht

10/04 · Labcorp Declares Quarterly Dividend · Persbericht

9/04 · Mynd.ai Announces CEO Transition · Persbericht

9/04 · Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease · Persbericht

8/04 · Cegedim: Release of its 2024 Universal Registration Document · Persbericht

2/04 · Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening · Persbericht

2/04 · Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease · Persbericht

1/04 · Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025 · Persbericht

1/04 · Labcorp to Offer HPV and STI Self-Collection Options in Labcorp Patient Service Centers and Participating Physician Offices Nationwide · Persbericht

31/03 · Labcorp to Announce First Quarter Financial Results on April 29, 2025 · Persbericht

28/03 · Equasens: 2024 annual results · Persbericht

Mijn selecties